{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:17:19Z","timestamp":1789028239838,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T00:00:00Z","timestamp":1563926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T00:00:00Z","timestamp":1563926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIH","award":["P30CA014236"],"award-info":[{"award-number":["P30CA014236"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1245\/s10434-019-07556-9","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T15:02:50Z","timestamp":1563980570000},"page":"3124-3132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["DCIS with Microinvasion: Is It In Situ or Invasive Disease?"],"prefix":"10.1245","volume":"26","author":[{"given":"Cosette D.","family":"Champion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwadamilola M.","family":"Fayanju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura H.","family":"Rosenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A.","family":"Greenup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.","family":"Menendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Shelley","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7411-0558","authenticated-orcid":false,"given":"Jennifer K.","family":"Plichta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,24]]},"reference":[{"key":"7556_CR1","unstructured":"Gradishar WJ, Anderson BO, Aft R, et al. NCCN guidelines: breast cancer, version 1. 2018. 20 March 2018."},{"issue":"41","key":"7556_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/jncimonographs\/lgq026","volume":"2010","author":"HM Shapiro-Wright","year":"2010","unstructured":"Shapiro-Wright HM, Julian TB. Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;2010(41):145\u2013149.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"7556_CR3","first-page":"e026797","volume":"9","author":"ES Hwang","year":"2018","unstructured":"Hwang ES, Hyslop T, Lynch T, et al. The COMET (Comparison of Operative to Monitoring and Endocrine Therapy) Trial: a phase III randomized trial for low-risk ductal carcinoma in situ (DCIS). BMJ. 2018;9:e026797.","journal-title":"BMJ"},{"issue":"12","key":"7556_CR4","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","volume":"51","author":"LE Elshof","year":"2015","unstructured":"Elshof LE, Tryfonidis K, Slaets L, et al. Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study. Eur J Cancer. 2015;51(12):1497\u2013510.","journal-title":"Eur J Cancer"},{"issue":"1","key":"7556_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.clon.2014.09.015","volume":"27","author":"A Francis","year":"2015","unstructured":"Francis A, Fallowfield L, Rea D. The LORIS Trial: Addressing overtreatment of ductal carcinoma in situ. Clin oncol (R Coll Radiol (Great Britain)). 2015;27(1):6\u20138.","journal-title":"Clin oncol (R Coll Radiol (Great Britain))"},{"issue":"1","key":"7556_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijrobp.2010.08.027","volume":"82","author":"RR Parikh","year":"2012","unstructured":"Parikh RR, Haffty BG, Lannin D, Moran MS. Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation. Int J Radiat Oncol Biol Phys. 2012;82(1):7\u201313.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7556_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijsu.2015.05.013","volume":"19","author":"Y Li","year":"2015","unstructured":"Li Y, Zhang S, Wei X, Zhang J. The clinical features and management of women with ductal carcinoma in situ with microinvasion: a retrospective cohort study. Int J Surg (London, Engl). 2015;19:91\u20134.","journal-title":"Int J Surg (London, Engl)."},{"issue":"39","key":"7556_CR8","doi-asserted-by":"publisher","first-page":"64182","DOI":"10.18632\/oncotarget.11639","volume":"7","author":"Y Fang","year":"2016","unstructured":"Fang Y, Wu J, Wang W, et al. Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion. Oncotarget. 2016;7(39):64182\u201390.","journal-title":"Oncotarget"},{"key":"7556_CR9","doi-asserted-by":"publisher","first-page":"42045","DOI":"10.1038\/srep42045","volume":"7","author":"W Wang","year":"2017","unstructured":"Wang W, Zhu W, Du F, Luo Y, Xu B. The demographic features, clinicopathological characteristics and cancer-specific outcomes for patients with microinvasive breast cancer: a SEER database analysis. Sci. Rep. 2017;7:42045.","journal-title":"Sci. Rep."},{"issue":"3","key":"7556_CR10","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s10549-017-4572-2","volume":"167","author":"V Sopik","year":"2018","unstructured":"Sopik V, Sun P, Narod SA. Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ. Breast Cancer Res Treat. 2018;167(3):787\u201395.","journal-title":"Breast Cancer Res Treat."},{"key":"7556_CR11","unstructured":"Adjusted AJCC 6th ed. T, N, M, and Stage. National Cancer Institute\u2019s Surveillance, Epidemiology, and End Results Program. \n                    https:\/\/seer.cancer.gov\/seerstat\/variables\/seer\/ajcc-stage\/6th\/#cs\n                    \n                  . Accessed 16 Apr 2019."},{"key":"7556_CR12","volume-title":"AJCC cancer staging manual","author":"GN Hortobagyi","year":"2016","unstructured":"Hortobagyi GN, Connolly JL, D'Orsi CJ, et al. Breast. In: Amin MB, Gress DM, Meyer Vega LR, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, Compton CC, editors. AJCC cancer staging manual. 8th edn. New York, NY: Springer; 2016.","edition":"8"},{"issue":"44","key":"7556_CR13","doi-asserted-by":"publisher","first-page":"e13055","DOI":"10.1097\/MD.0000000000013055","volume":"97","author":"ZB Wan","year":"2018","unstructured":"Wan ZB, Gao HY, Wei L, et al. Expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 in ductal carcinoma in situ (DCIS) and DCIS with microinvasion. Medicine (Baltimore). 2018;97(44):e13055.","journal-title":"Medicine (Baltimore)."},{"issue":"12","key":"7556_CR14","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1245\/s10434-017-6018-9","volume":"24","author":"LJ Grimm","year":"2017","unstructured":"Grimm LJ, Ryser MD, Partridge AH, et al. Surgical upstaging rates for vacuum assisted biopsy proven DCIS: implications for active surveillance trials. Ann Surg Oncol. 2017;24(12):3534\u20133540.","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"7556_CR15","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jamasurg.2017.2181","volume":"152","author":"CC de Paz Villanueva","year":"2017","unstructured":"de Paz Villanueva CC, Bonev V, Senthil M, et al. Factors associated with underestimation of invasive cancer in patients with ductal carcinoma in situ: precautions for active surveillance. JAMA Surg. 2017;152(11):1007\u201314.","journal-title":"JAMA Surg."},{"issue":"11","key":"7556_CR16","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1001\/archsurg.2010.243","volume":"145","author":"ED Kurniawan","year":"2010","unstructured":"Kurniawan ED, Rose A, Mou A, et al. Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ. Arch Surg. 2010;145(11):1098\u2013104.","journal-title":"Arch Surg."},{"issue":"1","key":"7556_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1245\/s10434-013-3239-4","volume":"21","author":"L Chin-Lenn","year":"2014","unstructured":"Chin-Lenn L, Mack LA, Temple W, et al. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy. Ann Surg Oncol. 2014;21(1):66\u201373.","journal-title":"Ann Surg Oncol."},{"issue":"14","key":"7556_CR18","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1056\/NEJMra031301","volume":"350","author":"HJ Burstein","year":"2004","unstructured":"Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM. Ductal carcinoma in situ of the breast. N Engl J Med. 2004;350(14):1430\u201341.","journal-title":"N Engl J Med."},{"issue":"1","key":"7556_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10549-017-4644-3","volume":"169","author":"SA Narod","year":"2018","unstructured":"Narod SA, Sopik V. Is invasion a necessary step for metastases in breast cancer? Breast Cancer Res Treat. 2018;169(1):9\u201323.","journal-title":"Breast Cancer Res Treat."},{"issue":"3","key":"7556_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s10549-018-4716-z","volume":"169","author":"V Giannakeas","year":"2018","unstructured":"Giannakeas V, Sopik V, Narod SA. A comparison of two models for breast cancer mortality for women with ductal carcinoma in situ: an SEER-based analysis. Breast Cancer Res Treat. 2018;169(3):587\u201394.","journal-title":"Breast Cancer Res Treat."},{"issue":"15","key":"7556_CR21","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1158\/1078-0432.CCR-04-0165","volume":"10","author":"ES Hwang","year":"2004","unstructured":"Hwang ES, DeVries S, Chew KL, et al. Patterns of chromosomal alterations in breast ductal carcinoma in situ. Clin Cancer Res. 2004;10(15):5160\u20137.","journal-title":"Clin Cancer Res."},{"issue":"18","key":"7556_CR22","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1158\/0008-5472.CAN-15-0506","volume":"75","author":"MC Abba","year":"2015","unstructured":"Abba MC, Gong T, Lu Y, et al. A molecular portrait of high-grade ductal carcinoma in situ. Cancer Res. 2015;75(18):3980\u201390.","journal-title":"Cancer Res."},{"issue":"9","key":"7556_CR23","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1245\/s10434-008-0051-7","volume":"15","author":"RE Ellsworth","year":"2008","unstructured":"Ellsworth RE, Vertrees A, Love B, Hooke JA, Ellsworth DL, Shriver CD. Chromosomal alterations associated with the transition from in situ to invasive breast cancer. Ann Surg Oncol. 2008;15(9):2519\u201325.","journal-title":"Ann Surg Oncol."},{"issue":"14","key":"7556_CR24","doi-asserted-by":"publisher","first-page":"4446","DOI":"10.1158\/1078-0432.CCR-07-4960","volume":"14","author":"VV Iakovlev","year":"2008","unstructured":"Iakovlev VV, Arneson NC, Wong V, et al. Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study. Clin Cancer Res. 2008;14(14):4446\u201354.","journal-title":"Clin Cancer Res."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07556-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-07556-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07556-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T23:12:51Z","timestamp":1595459571000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-07556-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,24]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["7556"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-07556-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,24]]},"assertion":[{"value":"22 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}